COMPANIES COVERED
GE HealthcareDownload FREE Report Sample
Download Free sampleNuclear imaging in cardiac disorders aids in accurate diagnosis of cardiovascular diseases and blockages in blood flow. Nuclear imaging is a technique for producing images of various body parts utilizing radioactive materials. This technique has applications in diagnosis of various cardiovascular diseases such as angina, aneurysm, atherosclerosis, stroke, coronary artery disease and congestive heart failure. Accurate diagnosis of such chronic diseases is essential to plan precise and cost-effective therapeutic module.
Nuclear Cardiology Market contains market size and forecasts of Nuclear Cardiology in Global, including the following market information:
Global Nuclear Cardiology Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Nuclear Cardiology market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Radiology Devices Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Nuclear Cardiology include GE Healthcare, Shimadzu, Siemens Healthcare, Fujifilm Medical, Astellas Pharma, Philips Healthcare, Medtronic, 3mensio Medical Imaging and Bracco Diagnostics and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Nuclear Cardiology companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Nuclear Cardiology Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Nuclear Cardiology Market Segment Percentages, by Type, 2021 (%)
Radiology Devices
Radiology Information Systems (RIS)
Radiopharmaceuticals
Global Nuclear Cardiology Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Nuclear Cardiology Market Segment Percentages, by Application, 2021 (%)
Hospitals
Clinics
Academic and Research Institutes
Others
Global Nuclear Cardiology Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Nuclear Cardiology Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Nuclear Cardiology revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Nuclear Cardiology revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
GE Healthcare
Shimadzu
Siemens Healthcare
Fujifilm Medical
Astellas Pharma
Philips Healthcare
Medtronic
3mensio Medical Imaging
Bracco Diagnostics
UltraSPECT
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
